About Inmune Bio (INMB)
INmune Bio Inc. operates as a clinical stage biotechnology company. The Company develops medicines to treat cancer. INmune Bio serves clients in the United States.
- USD11.17
- USD11.75
- USD11.12
- USD14.74
- 1.60%
- 0M
- 124.76k
- 181.38k
- 212M
- 6.50
- 44.90%
Stock News
2 hours ago
Here's how much money you'd have lost if you invested $1,000 in Peloton when it went public
CNBC
2 hours ago
SiriusXM to Present at the 52nd Annual J.P. Morgan Global Technology, Media and Communications Conference
Yahoo
2 hours ago
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo
2 hours ago
Skittles is giving away a 1-year stay in an NYC micro-apartment that usually rents for $3,500/month: Take a look inside
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
